- 2021 BECE for private candidates to begin in April
- Walewale: 3 in police custody test positive for coronavirus
- Kasoa slay queen dies after twerking naked on stage in a $100 challenge
- Volta FDA adjudged best, annexing four other awards for excellence and hard work
- Ho Central Market women disregard COVID-19 protocols
- Hohoe: Parents urged to support government in ensuring safety of students
WHO adds new drugs to 2017 essential medicines list
Related Articles
The World Health Organization (WHO) has released this year’s Essential Medicines List (EML), adding new treatments for HIV, hepatitis C virus (HCV), tuberculosis, and leukemia.
The list, which is comprised of medicine considered be most important for addressing public health needs, includes 433 drugs, with 30 new drugs for adults and 25 new ones for children as well as additional indications for nine existing drugs.
A major revision to the antibiotics section includes the categorization of these agents into three groups: ACCESS, WATCH, and RESERVE. These categories are currently applied to antibiotics indicated for 21 of the most common infections; recommendations on when each category should be used are also provided. The grouping is intended to help boost treatment outcomes, decrease the development of drug-resistant bacteria, and save the “last resort” antibiotics that may be needed.
ACCESS group antibiotics (eg, amoxicillin) should be available at all times to treat a variety of common infections.
WATCH group antibiotics (eg, ciprofloxacin) are those recommended as first- or second-line treatments for a smaller number of infections (eg, cystitis, upper respiratory tract infections), which should be used significantly less to reduce the development of resistance.
RESERVE group antibiotics (eg, colistin, some cephalosporins) include “last resort’ options that should only be used in the most severe situations when other alternatives have failed (eg, multidrug-resistant bacteria).
Some of other new drugs added to the WHO Essential Medicines List include:
– Dasatinib and nilotinib for chronic myeloid leukemia resistant to standard treatment
– Sofosbuvir + velpatasvir to treat all six types of HCV
– Dolutegravir for HIV
– Tenofovir +/- emtricitabine or lamivudine for HIV pre-exposure prophylaxis (PrEP)
– Delamanid and clofazime for multi-drug resistant tuberculosis
– Isoniazid, rifampicin, ethambutol, pyrazinamide for pediatric tuberculosis
– Fentanyl skin patches and methadone for pain management in cancer patients particularly for end-of-life care
The WHO Essential Medicines List was initially launched in 1977 and is revised every two years by the Expert Committee on the Selection and Use of Essential Medicines.
Source: Myjoyonline.com
No Comments
Write a comment
LATEST STORIES
Recent Comments
-
Sammy the VIRUS
In my estimation,I believe the average man in his quest to satisfy his libido will stop at nothing to have…
View Article -
Sammy the VIRUS
There is this maxim within our local circles that says a man who works at Barkleys bank does not collect…
View Article -
Sammy the VIRUS
To think that such things can still happen in Ghana beats my imagination
View Article
Let me tell You a sad story ! There are no comments yet, but You can be first one to comment this article.
Write a comment